Related Experiment Videos
S-(2-(acylamino)phenyl) 2,2-dimethylpropanethioates as CETP inhibitors
Kimiya Maeda1, Hiroshi Okamoto, Hisashi Shinkai
1Central Pharmaceutical Research Institute, JT Inc., 1-1 Murasaki-cho, Takatsuki, Osaka 569-1125, Japan.
Bioorganic & Medicinal Chemistry Letters
|April 28, 2004
Summary
Researchers explored how benzene ring structures in S-(2-(acylamino)phenyl) 2,2-dimethylpropanethioates affect cholesteryl ester transfer protein (CETP) inhibition. Electron-withdrawing groups enhanced CETP inhibitory activity, with the best compound inhibiting 50% at 2 microM.
Area of Science:
- Medicinal Chemistry
- Biochemistry
- Pharmacology
Background:
- Cholesteryl ester transfer protein (CETP) plays a key role in lipoprotein metabolism.
- Inhibiting CETP is a therapeutic strategy for modulating lipid profiles.
- Understanding structure-activity relationships is crucial for drug development.
Purpose of the Study:
- To investigate the impact of structural modifications on the benzene moiety of S-(2-(acylamino)phenyl) 2,2-dimethylpropanethioates.
- To identify key structural features that enhance CETP inhibitory activity.
Main Methods:
- Synthesis of S-(2-(acylamino)phenyl) 2,2-dimethylpropanethioate derivatives with varying substituents on the benzene ring.
- Evaluation of CETP inhibitory activity in human plasma using biochemical assays.
Main Results:
- Substituents on the benzene moiety significantly influenced CETP inhibitory activity in a type- and position-dependent manner.
- Electron-withdrawing groups, particularly at the 4- or 5-position of the benzene ring, increased CETP inhibitory potency.
- The most potent compound achieved 50% inhibition of CETP activity at a concentration of 2 microM.
Conclusions:
- Structural modifications of the benzene moiety are critical for optimizing CETP inhibitory activity.
- The findings provide valuable insights for the design of novel CETP inhibitors for potential therapeutic applications.